RTI Surgical® Schedules Fourth Quarter and Full Year 2018 Earnings Call for February 28, 2019
ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) — RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced […]
Agios Reports Fourth Quarter and Full Year 2018 Financial Results
– Strong Launch of TIBSOVO® Continues with Net Revenue of $9.4M for the Fourth Quarter and $13.8M for Full Year […]
Athenex, Inc. to Report Fourth Quarter and Fiscal Year 2018 Earnings Results on March 11, 2019
BUFFALO, N.Y., Feb. 14, 2019 (GLOBE NEWSWIRE) — Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, […]
Pool Corporation Reports Record 2018 Results and Provides 2019 Earnings Guidance
Highlights include: Record annual sales of $3.0 billion for 2018, up 8% from 2017 2018 operating margin of 10.5%, up […]
Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria
REDWOOD CITY, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that […]
Evelo Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
— First Patient Dosed in University of Chicago Phase 2a Trial of EDP1503 in Metastatic Melanoma —— Preclinical Studies Have […]
Recro Pharma to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call and Webcast on February 19, 2019
Conference Call and Webcast Scheduled for Tuesday, February 19, 2019 at 8:00 a.m. ET MALVERN, Pa., Feb. 14, 2019 (GLOBE […]
EyePoint Pharmaceuticals Announces Fiscal Period Ended December 31, 2018 Financial Results Release Date and Conference Call Information
WATERTOWN, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and […]
Aravive Expands Executive Team with Promotion of Gail McIntyre, PhD, DABT to Chief Scientific Officer
HOUSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, announced that the company has […]
Axogen, Inc. to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26, 2019
ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative […]
